Standard BioTools Current Ratio 2010-2025 | LAB

Standard BioTools current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Standard BioTools Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-06-30 $0.51B $0.10B 5.16
2025-03-31 $0.34B $0.06B 6.12
2024-12-31 $0.38B $0.07B 5.70
2024-09-30 $0.45B $0.12B 3.76
2024-06-30 $0.48B $0.12B 3.88
2024-03-31 $0.55B $0.12B 4.51
2023-12-31 $0.16B $0.11B 1.45
2023-09-30 $0.17B $0.05B 3.30
2023-06-30 $0.18B $0.05B 3.91
2023-03-31 $0.20B $0.04B 4.45
2022-12-31 $0.21B $0.04B 4.81
2022-09-30 $0.23B $0.05B 4.96
2022-06-30 $0.25B $0.04B 5.87
2022-03-31 $0.07B $0.05B 1.55
2021-12-31 $0.07B $0.05B 1.45
2021-09-30 $0.07B $0.05B 1.55
2021-06-30 $0.08B $0.05B 1.48
2021-03-31 $0.10B $0.05B 1.80
2020-12-31 $0.12B $0.05B 2.17
2020-09-30 $0.12B $0.04B 2.87
2020-06-30 $0.08B $0.04B 2.05
2020-03-31 $0.08B $0.04B 2.33
2019-12-31 $0.10B $0.03B 2.93
2019-09-30 $0.10B $0.03B 2.89
2019-06-30 $0.11B $0.04B 2.86
2019-03-31 $0.11B $0.03B 3.26
2018-12-31 $0.13B $0.04B 3.38
2018-09-30 $0.07B $0.04B 1.85
2018-06-30 $0.08B $0.04B 2.05
2018-03-31 $0.08B $0.03B 2.40
2017-12-31 $0.10B $0.03B 2.83
2017-09-30 $0.10B $0.03B 3.02
2017-06-30 $0.08B $0.03B 2.31
2017-03-31 $0.09B $0.03B 2.75
2016-12-31 $0.10B $0.03B 3.28
2016-09-30 $0.11B $0.03B 3.87
2016-06-30 $0.13B $0.03B 3.93
2016-03-31 $0.14B $0.03B 4.52
2015-12-31 $0.14B $0.03B 4.79
2015-09-30 $0.15B $0.03B 5.29
2015-06-30 $0.14B $0.03B 4.96
2015-03-31 $0.16B $0.03B 6.23
2014-12-31 $0.16B $0.03B 5.31
2014-09-30 $0.13B $0.03B 4.86
2014-06-30 $0.13B $0.03B 4.67
2014-03-31 $0.18B $0.03B 6.95
2013-12-31 $0.11B $0.02B 5.83
2013-09-30 $0.09B $0.02B 5.76
2013-06-30 $0.08B $0.01B 6.93
2013-03-31 $0.10B $0.01B 8.54
2012-12-31 $0.10B $0.01B 8.73
2012-09-30 $0.11B $0.01B 8.04
2012-06-30 $0.06B $0.02B 3.77
2012-03-31 $0.06B $0.02B 3.19
2011-12-31 $0.07B $0.02B 3.47
2011-09-30 $0.08B $0.02B 3.87
2011-06-30 $0.08B $0.02B 4.56
2011-03-31 $0.09B $0.02B 4.90
2010-12-31 $0.02B $0.02B 1.13
2010-09-30 $0.02B $0.01B 1.60
2010-06-30 $0.00B 0.00
2010-03-31 $0.00B 0.00
2009-09-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.470B $0.174B
Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.412B 59.05
Tempus AI (TEM) United States $12.731B 0.00
Doximity (DOCS) United States $12.055B 53.63
Hims & Hers Health (HIMS) United States $9.805B 80.33
IRhythm Technologies (IRTC) United States $5.243B 0.00
Hinge Health (HNGE) United States $4.466B 0.00
Inspire Medical Systems (INSP) United States $2.752B 40.46
Privia Health (PRVA) United States $2.596B 192.27
Heartflow (HTFL) $2.379B 0.00
Enovis (ENOV) United States $1.715B 9.06
10x Genomics (TXG) United States $1.663B 0.00
Phreesia (PHR) United States $1.648B 0.00
Omnicell (OMCL) United States $1.458B 28.10
Schrodinger (SDGR) United States $1.425B 0.00
Clover Health Investments (CLOV) United States $1.302B 0.00
Claritev (CTEV) United States $1.088B 0.00
Evolent Health (EVH) United States $1.052B 0.00
Fulgent Genetics (FLGT) United States $0.654B 0.00
Zepp Health (ZEPP) Netherlands $0.568B 0.00
Veradigm (MDRX) United States $0.531B 0.00
Talkspace (TALK) United States $0.430B 128.50
Butterfly Network (BFLY) United States $0.355B 0.00
Carlsmed (CARL) United States $0.320B 0.00
TruBridge (TBRG) United States $0.291B 51.03
SOPHiA GENETICS SA (SOPH) Switzerland $0.242B 0.00
Outset Medical (OM) United States $0.237B 0.00
Nyxoah SA (NYXH) Belgium $0.216B 0.00
Health Catalyst (HCAT) United States $0.205B 0.00
KORU Medical Systems (KRMD) United States $0.192B 0.00
CapsoVision (CV) United States $0.184B 0.00
MDxHealth SA (MDXH) Belgium $0.139B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.133B 0.00
CareCloud (CCLD) United States $0.112B 5.08
American Well (AMWL) United States $0.111B 0.00
EUDA Health Holdings (EUDA) Singapore $0.077B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.072B 0.00
111 (YI) China $0.063B 0.00
Pulmonx (LUNG) United States $0.062B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
HeartBeam (BEAT) United States $0.039B 0.00
Precipio (PRPO) United States $0.024B 0.00
Zhongchao (ZCMD) China $0.022B 0.00
Healthcare Triangle (HCTI) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
HeartSciences (HSCS) United States $0.009B 0.00
Strata Skin Sciences (SSKN) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
PROFUSA (PFSA) United States $0.003B 0.00